PAR23 COST-UTILITY OF ABATACEPT, A NEW BIOLOGIC TREATMENT FOR PATIENTS WITH RHEUMATOID ARTHRITIS WHO FAILED ANTI-TNF THERAPY
Nov 1, 2007, 00:00
10.1016/S1098-3015(10)64938-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)64938-8/fulltext
Title :
PAR23 COST-UTILITY OF ABATACEPT, A NEW BIOLOGIC TREATMENT FOR PATIENTS WITH RHEUMATOID ARTHRITIS WHO FAILED ANTI-TNF THERAPY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64938-8&doi=10.1016/S1098-3015(10)64938-8
First page :
Section Title :
Open access? :
No
Section Order :
99